Presence and phenotype of dendritic cells in uveal melanoma

被引:17
作者
Polak, Marta E.
Borthwick, Nicola J.
Johnson, Penny
Hungerford, John L.
Higgins, Bernie
Di Palma, Silvana
Jager, Martine J.
Cree, Ian A.
机构
[1] Queen Alexandra Hosp, Translat Oncol Res Ctr, Portsmouth PO6 3LY, Hants, England
[2] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands
[3] Inst Ophthalmol, Dept Pathol, London, England
[4] Univ Surrey, Dept Histopathol, RSCH, Guildford GU2 5XH, Surrey, England
[5] Moorfields Eye Hosp, Dept Pathol, London, England
[6] Univ Portsmouth, SHSSW, Portsmouth, Hants, England
关键词
D O I
10.1136/bjo.2006.110908
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Uveal melanoma arises in an immune- privileged site and can itself add to the immunosuppressive environment. Previous studies on cutaneous melanoma have shown the presence of tolerogenic dendritic cells ( DCs), which could play an important role in the progression of the tumour. Aim: To examine the presence and functional status of DCs in a small series of uveal melanomas. Methods: 10 cases of uveal melanoma were examined for the expression of FXIIIa, CD68, human leucocyte antigen ( HLA)- DR, CD40, CD83, transforming growth factor bR1 and indolamine 2,3 dioxygenase by immunohistochemical analysis on sections embedded in paraffin wax. Results: CD68- positive macrophages were present in all of the tumours and were evenly distributed throughout. DCs expressing FXIIIa- positive were seen in 7 cases, and were often found concentrated in foci within the tumour mass. These cells were dendritic and expressed high levels of HLA- DR. The DCs did not express the maturation markers CD83 or CD40. In one case, concentration of DCs around the area of tumour necrosis was observed, and some of these cells expressed CD83. Conclusion: Numerous tolerising antigen- presenting cells may play a role in melanoma- related immunosuppression in the eye, although activation of DCs may be associated with tumour necrosis.
引用
收藏
页码:971 / 976
页数:6
相关论文
共 39 条
  • [31] Stein-Streilein Joan, 2002, Int Rev Immunol, V21, P123, DOI 10.1080/08830180212066
  • [32] STEINMAN RM, 1993, ADV EXP MED BIOL, V329, P1
  • [33] Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review
    Suciu-Foca, N
    Manavalan, JS
    Scotto, L
    Kim-Schulze, S
    Galluzzo, S
    Naiyer, AJ
    Fan, JS
    Vlad, G
    Cortesini, R
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2005, 5 (01) : 7 - 11
  • [34] Tamura M, 1999, AM J REPROD IMMUNOL, V42, P160
  • [35] Microcirculation and tumor-infiltrating macrophages choroidal and ciliary body melanoma and corresponding metastases
    Toivonen, P
    Mäkitie, T
    Kujala, E
    Kivelä, T
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (01) : 1 - 6
  • [36] Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication
    van Mierlo, GJD
    Boonman, ZFHM
    Dumortier, HMH
    den Boer, AT
    Fransen, MF
    Nouta, J
    van der Voort, EIH
    Offringa, R
    Toes, REM
    Melief, CJM
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (11) : 6753 - 6759
  • [37] Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction
    Vieira, PL
    de Jong, EC
    Wierenga, EA
    Kapsenberg, ML
    Kalinski, P
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (09) : 4507 - 4512
  • [38] Evidence of macrophage and lymphocyte, but not dendritic cell, infiltration in posterior uveal melanomas, whilst cultured uveal melanomas demonstrate pluripotency by expressing CD68 and CD163
    Woodward, J
    Sisley, K
    Reeves, G
    Nichols, C
    Parsons, MA
    Mudhar, H
    Rennie, I
    [J]. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2004, 85 (01) : 35 - 43
  • [39] Distinct populations of dendritic cells in the normal human donor corneal epithelium
    Yamagami, S
    Yokoo, S
    Usui, T
    Yamagami, H
    Amano, S
    Ebihara, N
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (12) : 4489 - 4494